Delivery Order SPE2DB24D2018-SPE2DB25FWVC5
Award Date
6/16/25
Potential Completion Date
7/9/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAVALISSE 150 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $9,296.97 and a period of performance through May 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, is for the delivery of TAVALISSE 100 MG TABLET 60S, with a ceiling value of $9,266.70 and a performance period through June 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TAVALISSE 100 MG TABLET 60S, a prescription medication, with a ceiling value of $9,266.70 and a period of performance through May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
This is a $9,266.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAVALISSE 100 MG TABLET 60S, a medical product, with a performance period ending on July 8, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TAVALISSE 150 MG TABLET 60S. The contract has a firm fixed price of $18,563.67 and an ultimate completion date of May 13, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,266.70, is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $9,266.70 and runs through March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,266.70 firm fixed-price delivery order is for the supply of TAVALISSE 100 MG TABLET 60S, a medical product, with a period of performance through March 19, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award ceiling value of $9,266.70 and is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,574.23 firm fixed-price delivery order is for the provision of TAVALISSE 100 MG TABLET 60S, a medical product, with a completion date of December 10, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FH8CK, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,266.70, is a delivery order for TAVALISSE 100 MG TABLET 60S. It is a firm fixed-price contract with a completion date of January 30, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...